Page last updated: 2024-10-23

bunazosin and Weight Gain

bunazosin has been researched along with Weight Gain in 1 studies

bunazosin: structure

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research Excerpts

ExcerptRelevanceReference
"To determine whether bunazosin (alpha 1-adrenoceptor blocking agent) can alter the hemodynamic profile of chronic heart failure secondary to myocardial infarction, the drug was administered to Wistar rats 4 weeks after coronary ligation, and continued for 4 weeks."7.67Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure. ( Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T, 1989)
"To determine whether bunazosin (alpha 1-adrenoceptor blocking agent) can alter the hemodynamic profile of chronic heart failure secondary to myocardial infarction, the drug was administered to Wistar rats 4 weeks after coronary ligation, and continued for 4 weeks."3.67Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure. ( Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itagaki, T1
Toma, Y1
Umemoto, S1
Yamakawa, K1
Yoshinaga, T1
Fukuta, S1
Kusukawa, R1

Other Studies

1 other study available for bunazosin and Weight Gain

ArticleYear
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
    Japanese circulation journal, 1989, Volume: 53, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female;

1989